Even if the award went to Zhao Yi, the others who participated in the project could also bask in the glory!
Furthermore, they also released papers concerning related auxiliary results; thus, they can also sign the papers from major result researches.
For researchers in any field, influential results, worldwide recognized results, as well as papers are extrely important. Research outcos and papers are their working outcos. The more attention they receive, the more it represents the successful scientific research.
Everyone turned to look at Yan Xuelin with confusion.
Yan Xuelin chuckled, "The reason I went to Wucheng this ti was for the drug developnt project. Because the results are ours, they invited us to synchronously develop drugs."
"Does that an we’re getting another generous sponsorship?" Dai Tianqing was the first to catch on.
Ai Lixin hesitated and asked, "But we don’t specialize in drug developnt. We might not be able to solve problems encountered by their pharmaceutical company."
Yan Xuelin waved his hand and explained, "No problem. For confidentiality reasons, they can’t share information with any other parties, so their only option is to let us join the developnt process."
"Synchronous..."
Dai Tianqing hesitated and asked, "So that ans we don’t share information and each do our own independent research?"
Yan Xuelin nodded affirmatively, "Exactly! We develop simultaneously, with all expenses covered by them. If we achieve results, we’ll also get a share of the patent fees. That’s what I went to discuss this ti, and they have agreed to give us an initial sponsorship of 10 million. If we ultimately succeed, we will own 30% of the drug patent."
"Their sponsorship ans a 70-30 split...that’s not bad..." Dai Tianqing mused.
Ai Lixin retorted, "But we might not be able to deliver any results. The Pharma company’s research team must be facing major issues."
Yan Xuelin laughed, "Old Ai, don’t lose confidence. We haven’t even started yet. Even if we don’t yield any results, we won’t suffer any loss."
"That’s true." Everyone began to nod in agreent.
The matter was clear now.
When the pharmaceutical company was developing drugs and had problems that could not be solved in a short ti, they simply turned to a research institute for help. Compared to the discovery of the 2CV-Bing Hydrogen Molecule, additional research funding was nothing big.
They cannot seek help from other organizations because the secrecy applies not only to the research institute but also to the people within the Pharmaceutical Company who have access to their information. Therefore, they either have to conduct in-house research or find a research institute to assist them in their research.
Yan Xuelin’s trip to Wucheng was to discuss this matter, and the final agreent was that the pharmaceutical company sponsors research while developing the drug simultaneously. If results are produced, they would be calculated based on patents, with them getting 70% of the patent ownership ratio.
Every research institution hopes to attract outside enterprise sponsorship for research funding. The Biodical Research Institute is a national research institution, and most of its R&D funds are provided by the state. As they mostly engage in dical chanism research, external enterprise sponsorship for research funding is scant.
The Biodical Research Institute is not small in scale, but grants of 10 million from the beginning is indeed a massive project. More importantly, the institute will not incur any losses, all funds are taken care of by the pharmaceutical company, and whether or not results are yielded, the researchers involved will gain so drug developnt experience.
If results are successfully obtained, that would be even better. Thirty percent of patent ownership is indeed significant, especially for the 2CV-Bing Hydrogen Molecule patent.
The institute understands the effect of the 2CV-Bing Hydrogen Molecule very well. The drug developed around the 2CV-Bing Hydrogen Molecule will undoubtedly be effective against AIDS, and it may sell well dostically and internationally, leading to continuous substantial benefits from its 30% drug patent.
Furthermore, the developnt of AIDS drugs holds great significance. Currently, China does not have any dostically produced AIDS dicine available in the market; all prescribed drugs for treatnt are imported. Since the research institute discovered the effect of the 2CV-Bing Hydrogen Molecule, having ’developed relevant drugs’ could double their honor.
Combining both economic benefits and honor would attract anyone.
...
Yan Xuelin dropped the big news about synchronous drug developnt, and their small internal eting had just begun. He had visited the drug developnt base of a pharmaceutical company in Wucheng and understood the challenges faced in drug R&D.
In short, for now, there is no thod to synthetically produce 2CV-Bing Hydrogen Molecules, and producing 2CV-Bing Hydrogen Molecules based on immunization process in a laboratory environnt is too costly and inefficient.
The latter is self-explanatory.
When the 2CV-Bing Hydrogen Molecule was being studied previously, the lab-produced thods were based on simulating the immune environnt, generating antibodies against a bacterial invasion, and consequently manufacturing the 2CV-Bing Hydrogen Molecule.
To extract the 2CV-Bing Hydrogen Molecule, one needs to continually interrupt experints, add various chemical materials, and the process is extrely complicated. To extract a small tube of solution containing a trace amount of the 2CV-Bing Hydrogen Molecule, the lab cost could easily exceed ten thousand.
This small tube of solution would probably only be enough for two or three injections into the human body. With such treatnt, the entire solution would be used up before any effect was even witnessed. But for the 2CV-Bing Hydrogen Molecule drug, a broad estimate would require continuous injections for at least half a month, or even one month, or two months, until all the AIDS virus in the blood is ’controlled,’ to achieve the best results.
In simple terms, a daily injection costs over three thousand RMB, and the average use of one month would cost around a hundred thousand RMB.
Reviews
All reviews (0)